Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New interferon inducers described by Sumitomo and Japan Energy

Sep. 27, 1999

Cantab reports positive phase I results for DISC HSV vaccine

Sep. 24, 1999

Cytokine production modulators identified as part of Japanese pharmaceutical collaboration

Sep. 23, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Newly discovered metabolite of sinomenine with more potent immunosuppressive activity

Sep. 17, 1999

Seragen sublicenses daclizumab patents to Roche

Sep. 16, 1999

Interleukin Genetics applies for inflammatory gene patent

Sep. 15, 1999

Chiron seeks U.K. approval for meningitis vaccine

Sep. 14, 1999

Merck & Co. launches preservative-free HBV vaccine

Sep. 13, 1999

Selective glucocorticoid receptor modulators emerge from Abbott-Ligand collaboration

Sep. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...